160 related articles for article (PubMed ID: 30273383)
21. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to
Porter SN; Cluster AS; Yang W; Busken KA; Patel RM; Ryoo J; Magee JA
Elife; 2016 Nov; 5():. PubMed ID: 27879203
[TBL] [Abstract][Full Text] [Related]
22. Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.
Valent P; Kern W; Hoermann G; Milosevic Feenstra JD; Sotlar K; Pfeilstöcker M; Germing U; Sperr WR; Reiter A; Wolf D; Arock M; Haferlach T; Horny HP
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759825
[TBL] [Abstract][Full Text] [Related]
23. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.
Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG
Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417
[TBL] [Abstract][Full Text] [Related]
24. Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.
Lee JH; Salci KR; Reid JC; Orlando L; Tanasijevic B; Shapovalova Z; Bhatia M
Stem Cells; 2017 Sep; 35(9):2095-2102. PubMed ID: 28758276
[TBL] [Abstract][Full Text] [Related]
25. Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia.
Rampal R; Figueroa ME
Haematologica; 2016 Jun; 101(6):672-9. PubMed ID: 27252512
[TBL] [Abstract][Full Text] [Related]
26. Leukemic hematopoiesis in vitro: acute myeloid leukemia.
Löwenberg B; Touw I
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():5-8. PubMed ID: 2653517
[No Abstract] [Full Text] [Related]
27. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
28. Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.
Lai CK; Moon Y; Kuchenbauer F; Starzcynowski DT; Argiropoulos B; Yung E; Beer P; Schwarzer A; Sharma A; Park G; Leung M; Lin G; Vollett S; Fung S; Eaves CJ; Karsan A; Weng AP; Humphries RK; Heuser M
PLoS One; 2014; 9(11):e112671. PubMed ID: 25401736
[TBL] [Abstract][Full Text] [Related]
29. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
30. Myeloid lineage commitment from the hematopoietic stem cell.
Iwasaki H; Akashi K
Immunity; 2007 Jun; 26(6):726-40. PubMed ID: 17582345
[TBL] [Abstract][Full Text] [Related]
31. Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis.
Osorio FG; Rosendahl Huber A; Oka R; Verheul M; Patel SH; Hasaart K; de la Fonteijne L; Varela I; Camargo FD; van Boxtel R
Cell Rep; 2018 Nov; 25(9):2308-2316.e4. PubMed ID: 30485801
[TBL] [Abstract][Full Text] [Related]
32. Lineage switch from acute myeloid leukemia to T cell/myeloid mixed phenotype acute leukemia: First report of an adult case.
Hanley BP; Yebra-Fernandez E; Palanicawandar R; Olavarria E; Naresh KN
Am J Hematol; 2018 Dec; 93(12):E395-E397. PubMed ID: 30203419
[No Abstract] [Full Text] [Related]
33. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
Laing AA; Harrison CJ; Gibson BES; Keeshan K
Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
[TBL] [Abstract][Full Text] [Related]
34. SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia.
Dong S; Chen J
BMC Cancer; 2015 Nov; 15():893. PubMed ID: 26559765
[TBL] [Abstract][Full Text] [Related]
35. Maximum parsimony analysis of gene expression profiles permits the reconstruction of developmental cell lineage trees.
Joshi A; Göttgens B
Dev Biol; 2011 May; 353(2):440-7. PubMed ID: 21354129
[TBL] [Abstract][Full Text] [Related]
36. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R
Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908
[TBL] [Abstract][Full Text] [Related]
37. Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.
Wouters R; Cucchi D; Kaspers GJ; Schuurhuis GJ; Cloos J
Expert Rev Hematol; 2014 Dec; 7(6):791-805. PubMed ID: 25242511
[TBL] [Abstract][Full Text] [Related]
38. Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
Salomé M; Hopcroft L; Keeshan K
Exp Hematol; 2018 Oct; 66():63-78.e13. PubMed ID: 30031847
[TBL] [Abstract][Full Text] [Related]
39. Cancer stem cells: lessons from leukemia.
Wang JC; Dick JE
Trends Cell Biol; 2005 Sep; 15(9):494-501. PubMed ID: 16084092
[TBL] [Abstract][Full Text] [Related]
40. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.
Corces MR; Buenrostro JD; Wu B; Greenside PG; Chan SM; Koenig JL; Snyder MP; Pritchard JK; Kundaje A; Greenleaf WJ; Majeti R; Chang HY
Nat Genet; 2016 Oct; 48(10):1193-203. PubMed ID: 27526324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]